Nuo Therapeutics, Inc.
AURX- Exchange
- OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001091596
In the last 90 days, Nuo Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 1 institution reported holding it in 13F filings for Q2 2026, worth $4.28K in total; no superinvestor holds it.
Holders of 5% or more of AURX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Nuo Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Pittman Scott M. | 13D/A | 11.60%5.63M shares | 0.00 ppfrom 11.60% | Jan 26, 20262 filings | Jun 3, 2026 | SEC |
| Jacobs Paul Anthony | 13G/A | 6.60%3.18M shares | – | Feb 12, 20261 filing | Feb 12, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
3 Schedule 13D and 13G filings on Nuo Therapeutics, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Jun 3, 202611:04 AM ET | Pittman Scott M. | 13D/A | 11.60%5.63M shares | 0.00 ppfrom 11.60% | May 29, 2026 | SEC |
| Feb 12, 20264:43 PM ET | Jacobs Paul Anthony | 13G/A | 6.60%3.18M shares | – | Jan 23, 2026 | SEC |
| Jan 26, 20266:05 PM ET | Pittman Scott M. | 13D/A | 11.60%5.61M shares | – | Jan 23, 2026 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Nuo Therapeutics, Inc. shares.
No Form 144 notices for Nuo Therapeutics, Inc. are on file.